KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Work In Process: 2016-2025

Historic Work In Process for CareDx (CDNA) over the last 9 years, with Sep 2025 value amounting to $5.1 million.

  • CareDx's Work In Process rose 22.13% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 22.13%. This contributed to the annual value of $3.8 million for FY2024, which is 26.93% down from last year.
  • As of Q3 2025, CareDx's Work In Process stood at $5.1 million, which was down 9.17% from $5.7 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Work In Process registered a high of $5.7 million during Q2 2025, and its lowest value of $2.8 million during Q3 2021.
  • For the 3-year period, CareDx's Work In Process averaged around $4.8 million, with its median value being $4.9 million (2023).
  • In the last 5 years, CareDx's Work In Process spiked by 90.50% in 2021 and then decreased by 26.94% in 2024.
  • Over the past 5 years, CareDx's Work In Process (Quarterly) stood at $2.8 million in 2021, then skyrocketed by 52.26% to $4.3 million in 2022, then grew by 20.55% to $5.2 million in 2023, then declined by 26.93% to $3.8 million in 2024, then grew by 22.13% to $5.1 million in 2025.
  • Its Work In Process stands at $5.1 million for Q3 2025, versus $5.7 million for Q2 2025 and $4.8 million for Q1 2025.